Xianan Sang

787 citations
34 papers · 551 indexed · h-index 13
Topics
Liver Disease Diagnosis and Treatment (7 papers)Liver physiology and pathology (4 papers)Cancer-related molecular mechanisms research (3 papers)
Journals
SHILAP Revista de lepidopterologíaJournal of Controlled ReleaseJournal of Chromatography A
Partner nations
ChinaCanada

In The Last Decade

Xianan Sang

32 papers receiving 548 citations

Peers

Xianan Sang
Comparison fields: 5 of 90
  • Molecular Biology 294
  • Cancer Research 159
  • Epidemiology 95
  • Pharmacology 63
  • Complementary and alternative medicine 53
Replace Su‐Yu Chien with:
Su‐Yu Chien Taiwan
Weiming He China
Weiya Cao China
Tiantian Xu China
Kuilong Wang China
Yuzhen Zhuo China
Yuan Liang China
Subhayan Sur United States
Mengmeng Dou China
Xianan Sang relative to Su‐Yu Chien Taiwan Su‐Yu Chien's profile →
Citations per field
00.5×7.3×
Su‐Yu Chien · 1×
Citations per year

Countries citing papers authored by Xianan Sang

Since Specialization
Citations

This map shows the geographic impact of Xianan Sang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianan Sang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianan Sang more than expected).

Fields of papers citing papers by Xianan Sang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xianan Sang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianan Sang. The network helps show where Xianan Sang may publish in the future.

Co-authorship network of co-authors of Xianan Sang

This figure shows the co-authorship network connecting the top 25 collaborators of Xianan Sang. A scholar is included among the top collaborators of Xianan Sang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xianan Sang. Xianan Sang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 0
4 3
5 9
6 4
7 15
8 1
9 5
10 12
11 24
12 29
13 11
14 4
15 10
16 30
17 46
18 52
19 29
20 1

About Xianan Sang

Xianan Sang is a scholar working on Pharmacology, Hepatology and Geriatrics and Gerontology, having authored 34 papers that have together received 551 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (7 papers), Liver physiology and pathology (4 papers) and Cancer-related molecular mechanisms research (3 papers). The work is most often cited by research in Cancer Research (159 citations), Pharmacology (63 citations) and Geriatrics and Gerontology (28 citations). Xianan Sang has collaborated with scholars based in China and Canada. Frequent co-authors include Gang Cao, Kuilong Wang, Xin Han, Qiyuan Shan, Gang Cao, Xin Wu, Qiao Yang, Zhu Yang, Li Luo and Bing Yang. Their work appears in journals such as SHILAP Revista de lepidopterología, Journal of Controlled Release and Journal of Chromatography A.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026